Global Economy Helps India Attract Foreign Drug Makers
This article was originally published in PharmAsia News
Indian pharmaceutical companies are benefiting from the global economy that is causing multinational drug makers to trim their budgets. Many other nations are attempting to attract Indian drug makers to invest in their countries, with offers of tax advantages and other perks. Representatives of Australia, Belgium and Denmark are among representatives of foreign nations seeking a presence by Indian drug makers, seeking collaborations with home-country institutions. The representatives are trying to convince Indian drug makers to invest in facilities and even establish bases in their countries. (Click here for more
You may also be interested in...
Veklury is now the first US FDA-approved treatment for COVID-19, but its limited benefits means its lifespan as a blockbuster could be short.
As negotiations between the UK and EU enter a crucial phase, the UK life sciences industry has called for more clarity and guidance on what companies can expect to face at the end of the Brexit transition period.
Phase II results look good for one of the first-in-class product’s potential indications, C3 glomerulopathy. The product was highlighted late last year as an up-and-coming pipeline asset.